26 min listen
Carolyn Bertozzi and Degrading Drugs for Problematic Proteins
FromRaising Health
ratings:
Length:
24 minutes
Released:
Oct 6, 2022
Format:
Podcast episode
Description
In Bio Eats World's Journal Club episodes, we discuss groundbreaking research articles, why they matter, what new opportunities they present, and how to take these findings from paper to practice. In this episode, Stanford Professor Carolyn Bertozzi and former Bio Eats World host Lauren Richardson discuss the article "Lysosome-targeting chimaeras for degradation of extracellular proteins" by Steven M. Banik, Kayvon Pedram, Simon Wisnovsky, Green Ahn, Nicholas M. Riley & Carolyn R. Bertozzi, published in Nature 584, 291–297 (2020).Many diseases are caused by proteins that have gone haywire in some fashion. There could be too much of the protein, it could be mutated, or it could be present in the wrong place or time. So how do you get rid of these problematic proteins? Dr. Bertozzi and her lab developed a class of drugs -- or modality -- that in essence, tosses the disease-related proteins into the cellular trash can. While there are other drugs that work through targeted protein degradation, the drugs created by the Bertozzi team (called LYTACs) are able to attack a set of critical proteins, some of which have never been touched by any kind of drug before. Our conversation covers how they engineered these new drugs, their benefits, and how they can be further optimized and specialized in the future.
Released:
Oct 6, 2022
Format:
Podcast episode
Titles in the series (100)
Journal Club: Reversing Parkinson's with New Neurons: Parkinson's Disease is caused by the death of specific neurons in the brain. In this episode of the Bio Eats World Journal Club, we discuss research reprogramming non-neuronal brain cells (astrocytes) to become neurons to replace those lost to disease. This work paves the way for a potential cure for this devastating disease. by Raising Health